insights_auto
Why is INO down 3,97%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
1,45 USD
arrow_downward
-3,97%(-0,060) 1D
1,33 USD
arrow_downward
-8,28% (-0,12)todayPre-market
Closed: 10-ноя., 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
1,48 USD
High
1,51 USD
Low
1,40 USD
Mkt. cap
244,95 млн
Avg. vol.
18,40 млн
Volume
204,68 миң
52-wk high
2,72 USD
52-wk low
0,57 USD
EPS
-1,17 USD
Beta
1,71
Shares outstanding
103,40 млн
No. of employees
112
Open
1,48 USD
High
1,51 USD
Low
1,40 USD
Mkt. cap
244,95 млн
Avg. vol.
18,40 млн
Volume
204,68 миң
52-wk high
2,72 USD
52-wk low
0,57 USD
EPS
-1,17 USD
Beta
1,71
Shares outstanding
103,40 млн
No. of employees
112
News stories
From web sources and news partners
GuruFocus
·
7 саат мурун
FMR LLC Adds Inovio Pharmaceuticals Inc (INO) Shares -- Stock Looks 625% Overvalued on GF Value
TradingView
·
8 саат мурун
Inovio Pharmaceuticals Q3 2026 Earnings Call Is Live
Yahoo Finance
·
9 саат мурун
Inovio Pharmaceuticals Q3 Earnings Call Highlights
Investing.com Canada
·
12 саат мурун
Inovio Q3 2026 slides: VOCERYQ approval amid wider loss By Investing.com
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc